A R T I C L E S
Henry et al.
1.84 (1H, m). 19F NMR (CD3OD): δ -138.5 (1F, m), -143.6 (1F, m).
13C NMR (CD3OD): δ 131.9, 124.3, 122.1, 115.9, 115.6, 87.9, 73.8,
73.1, 72.1, 62.7, 42.4. HRMS (MALDI-FTMS): calcd for C11H12F2O3-
Na (MNa+), 253.0647; found, 253.0644.
121.9, 114.7, 114.3, 113.4, 112.9, 86.9, 86.5, 79.6, 74.5, 64.9, 55.5,
44.2. HRMS (MALDI-FTMS): calcd for C32H31FO5Na (MNa+),
537.2048; found, 537.2045.
Compound 2d. 1H NMR (CDCl3): δ 7.51-7.02 (12H, m), 6.98 (1H,
t, J ) 6.2 Hz), 6.87 (4H, d, J ) 8.4 Hz), 5.10 (1H, dd, J ) 10.0, 5.2
Hz), 4.41 (1H, dd, J ) 9.8, 5.5 Hz), 4.16 (1H, br s), 3.71 (6H, s),
3.65-3.40 (4H, m), 3.21 (2H, t, J ) 4.0 Hz), 2.46 (1H, t, J ) 6.2 Hz),
2.32 (1H, t, J ) 6.2 Hz), 2.28-2.01 (1H, m), 2.01-1.81 (1H, m), 1.25-
1
Compound 5b. H NMR (CDCl3): δ 7.31 (1H, dd, J ) 12.0, 8.6
Hz), 7.22-7.11 (2H, m), 5.08 (1H, dd, J ) 10.6, 5.4 Hz), 4.82 (1H, br
s), 4.32 (1H, d, J ) 6.0 Hz), 4.03-3.81 (1H, m), 3.67 (2H, d, J ) 4.6
Hz), 2.25-2.15 (1H, m), 1.95-1.80 (1H, m). 13C NMR (CDCl3): δ
139.9, 122.3, 117.0, 116.7, 115.0, 114.6, 88.1, 79.2, 73.2, 62.8, 43.9.
19F NMR (CDCl3): δ -140.53 (1F, ddd, J ) 23.8, 14.0, 5.3 Hz),
-142.36 (1F, dd, J ) 13.3, 6.6 Hz). HRMS (MALDI-FTMS): calcd
for C11H12F2NaO3 (MNa+), 253.0647; found, 253.0648.
0.95 (14H, m). 19F NMR (CDCl3): δ -113.42 (1F, d, J ) 5.6 Hz). 31
P
NMR (CDCl3): δ 149.16, 149.03. 13C NMR (CDCl3): δ 165.6, 160.8,
158.7, 145.2, 136.2, 130.4, 130.2, 130.0, 128.5, 128.1, 127.0, 121.8,
117.9, 114.7, 114.3, 113.4, 112.9, 86.4, 86.1, 86.0, 79.9, 76.2, 76.1,
75.8, 64.5, 58.8, 58.4, 55.4, 43.6, 43.4, 26.0, 24.8, 24.7, 20.7, 20.6,
20.4. HRMS (MALDI-FTMS): calcd for C41H49FN2O6P (MH+),
715.3312; found, 715.3310.
1
Compound 6b. H NMR (CD3OD): δ 7.40-7.32 (1H, m), 7.13-
6.99 (1H, m), 5.32 (1H, dd, J ) 10.2, 5.9 Hz), 4.34-4.30 (1H, m),
3.97-3.91 (1H, m), 3.71-3.64 (2H, m), 2.33-2.22 (1H, m), 2.00-
1.83 (1H, m). 19F NMR (CD3OD): δ -139.4 (1F, m), -143.2 (1F, m),
-161.1 (1F, m). 13C NMR (CD3OD): δ 121.2, 121.1, 112.2, 112.1,
111.8, 111.7, 87.9, 73.5, 73.0, 62.7, 42.3. HRMS (MALDI-FTMS):
calcd for C11H11F3O3Na (MNa+), 271.0552; found, 271.0559.
General Procedure for Phosphoramidite Synthesis. To a solution
of free nucleoside (0.6 mmol) coevaporated with toluene (10 mL) was
added pyridine (2.5 mL), followed by DMTr-Cl (1.5 equiv) in pyridine
(1.2 mL) over 10 min. After being stirred for an additional 30 min at
room temperature, ethyl acetate was added (50 mL), and the organic
phase was washed with saturated NaHCO3 (20 mL) and brine (20 mL)
and dried over Na2SO4. The solvent was removed in vacuo, and flash
column chromatography on silica gel (20-50% ethyl acetate in hexane)
yielded a light yellow foam. The tritylated nucleoside (0.2 mmol) was
dissolved in CH2Cl2 (2 mL), diisopropylethylamine (4 equiv) was added,
and the solution was cooled to 0 °C. 2-Cyanoethyl diisopropyl-
aminochloro phosphoramidite (1.3 equiv) was added dropwise, and the
reaction was allowed to reach room temperature over 15 min. The
solution was transferred to ethyl acetate (50 mL), and the organic phase
was washed with saturated NaHCO3 (20 mL) and brine (20 mL) and
dried over Na2SO4. The solvent was removed in vacuo and flash column
chromatography on silica gel washed with 2% triethylamine in hexane
(20% ethyl acetate in hexane with 2% triethylamine) afforded a white
foam. The phosphoramidite was generally obtained in 70% yield over
two steps, as a mixture of two diastereoisomers.
1
Compound 3c. H NMR (CDCl3): δ 7.51-7.20 (10H, m), 6.97-
6.70 (6H, m), 6.67-6.66 (1H, m), 5.12 (1H, t, J ) 7.4 Hz), 4.45 (1H,
br s), 4.19 (1H, d, J ) 6.4 Hz), 3.80 (6H, s), 3.40-3.20 (2H, m), 2.80-
2.61 (1H, m), 2.06-1.94 (1H, m). HRMS (MALDI-FTMS): calcd
for C32H31F2O5 (MH+), 533.2061; found, 533.2056.
1
Compound 3d. H NMR: 7.40-7.18 (12H, m), 6.89-6.62 (7H,
m), 5.11 (1H, m), 4.25-4.18 (1H, m), 4.18 (1H, br s), 3.81-3.40 (12H,
m), 3.20 (2H, t, J ) 6.6 Hz), 2.60-2.42 (2H, m), 2.32 (2H, t, J ) 6.5
Hz), 1.40 (1H, d, J ) 6.2 Hz), 1.19-0.96 (6H, m). 31P NMR (CDCl3):
δ 149.15, 149.06. HRMS (MALDI-FTMS): calcd for C41H48F2N2O5P
(MH+), 717.3191; found, 717.3187.
Compound 4c. 1H NMR (CDCl3): δ 7.47 (2H, d, J ) 7.8 Hz), 7.40-
7.18 (9H, m), 7.05 (2H, t, J ) 3.5 Hz), 6.83 (4H, d, J ) 8.6 Hz), 5.44
(1H, dd, J ) 9.7, 4.9 Hz), 4.43 (1H, t, J ) 3.0 Hz), 4.12 (1H, dd, J )
7.5, 3.0 Hz), 3.79 (6H, s), 3.36 (2H, t, J ) 4.8 Hz), 2.58 (1H, br s),
2.38 (1H, dd, J ) 12.8, 5.8 Hz), 2.10-1.90 (1H, m). 19F NMR (CDCl3):
δ -144.30 (1F, t, J ) 8.9 Hz), -139.77 (1F, dt, J ) 10.9, 5.3 Hz). 13
C
NMR (CDCl3): δ 158.7, 145.0, 136.2, 132.2, 130.3, 128.4, 128.1, 127.0,
124.2, 122.0, 116.3, 115.9, 113.4, 86.5, 86.4, 74.4, 74.1, 64.5, 55.5,
42.8. HRMS (MALDI-FTMS): calcd for C32H31F2O5 (MH+), 533.2140;
found, 533.2138.
Compound 4d. 1H NMR (CDCl3): δ 7.38 (2H, d, J ) 7.8 Hz), 7.26-
7.12 (9H, m), 6.97 (2H, dd, J ) 12.2, 5.6 Hz), 6.76-6.70 (4H, m),
5.34 (1H, dd, J ) 12.7, 5.2 Hz), 4.44 (1H, br s), 4.15 (1H, br s), 3.70
(6H, s), 3.69-3.40 (5H, m), 3.22 (2H, dd, J ) 9.8, 5.0 Hz), 2.52 (1H,
t, J ) 6.2 Hz), 2.37 (1H, t, J ) 6.2 Hz), 2.35-2.25 (1H, m), 1.98-
1.84 (1H, m), 1.25-0.96 (14H, m). 19F NMR (CDCl3): -144.46 (1F,
t, J ) 8.8 Hz), -139.88 (1F, dt, J ) 10.9, 5.3 Hz). 13C NMR (CDCl3):
δ 158.7, 145.0, 136.2, 130.4, 128.5, 128.0, 127.0, 124.3, 122.0, 116.3,
115.9, 113.3, 86.4, 85.8, 74.3, 64.1, 58.8, 58.4, 55.5, 43.7, 43.4, 42.1,
25.0, 24.8, 24.7, 20.6, 20.4. 31P NMR (CDCl3): δ 149.54, 149.01.
HRMS (MALDI-FTMS): calcd for C41H47F2N2NaO6P (MNa+),
755.3037; found, 755.3032.
Compound 1c. 1H NMR (CDCl3): δ 7.64-7.02 (13H, m), 6.85 (4H,
d, J ) 8.6 Hz), 5.48 (1H, dd, J ) 9.4, 6.0 Hz), 4.44 (1H, t, J ) 2.8
Hz), 4.13 (1H, dd, J ) 7.4, 5.0 Hz), 3.79 (6H, s), 3.34 (2H, t, J ) 5.0
Hz), 2.82 (1H, br s), 2.38 (1H, dd, J ) 13.2, 5.8 Hz), 2.18-1.95 (1H,
m). 19F NMR (CDCl3): δ -118.93 (1F, t, J ) 5.3 Hz). 13C NMR
(CDCl3): δ 162.5, 158.7, 157.6, 149.7, 145.2, 136.6, 136.3, 130.8, 129.7,
129.5, 129.0, 128.9, 128.5, 128.1, 127.5, 127.4, 127.1, 124.4, 124.3,
115.5, 115.1, 113.4, 110.0, 86.5, 86.3, 85.0, 75.0, 74.5, 74.4, 64.7, 55.5,
42.9. HRMS (MALDI-FTMS): calcd for C32H31FNaO5 (MNa+),
537.2053; found, 537.2051.
Compound 5c. 1H NMR (CDCl3): δ 7.51 (2H, d, J ) 8.2 Hz), 7.40
(4H, d, J ) 7.8 Hz), 7.38-7.22 (4H, m), 7.18-7.07 (2H, m), 6.86
(4H, d, J ) 7.4 Hz), 5.17 (1H, dd, J ) 9.8, 5.4 Hz), 4.43 (1H, d, J )
2.2 Hz), 4.19 (1H, br s), 3.79 (6H, s), 3.34 (2H, t, J ) 4.2 Hz), 2.27
(1H, dd, J ) 13.1, 5.6 Hz), 2.06-1.93 (1H, m). 19F NMR (CDCl3): δ
-138.15 (1F, dd, J ) 17.9, 7.3 Hz), -140.21 (1F, dd, J ) 14.5, 7.9
Hz). 13C NMR (CDCl3): δ 158.8, 149.4, 145.1, 139.6, 139.4, 136.2,
130.4, 130.2, 128.4, 128.1, 127.1, 122.3, 122.2, 122.2, 122.1, 117.4,
117.1, 115.4, 115.0, 113.4, 87.0, 86.6, 79.2, 74.4, 64.8, 55.5, 44.3.
HRMS (MALDI-FTMS): calcd for C32H30F2O5Na (MNa+), 555.1953;
found, 555.1948.
Compound 1d. 1H NMR (CDCl3): δ 7.51-7.02 (13H, m), 6.73 (4H,
dd, J ) 8.8, 2.6 Hz), 5.33 (1H, dd, J ) 10.3, 5.3 Hz), 4.46 (1H, br s),
4.15 (1H, br s), 3.74 (6H, s), 3.72-3.41 (4H, m), 3.23 (2H, t, J ) 4.6
Hz), 2.46 (1H, t, J ) 6.2 Hz), 2.44-2.39 (1H, m), 2.38 (1H, t, J ) 6.2
Hz), 1.97-1.81 (1H, m), 1.17-0.81 (14H, m). 19F NMR (CDCl3): δ
-119.12 (1F, d, J ) 5.3 Hz). 13C NMR (CDCl3): δ 158.7, 157.6, 151.1,
145.2, 136.3, 130.4, 129.2, 128.9, 128.5, 128.0, 127.5, 127.0, 124.4,
115.5, 115.1, 113.3, 110.0, 86.4, 85.8, 74.6, 64.4, 58.8, 58.4, 55.5, 43.6,
43.4, 42.2, 24.8, 24.3, 20.6. 31P NMR (CDCl3): δ 149.40, 148.87.
HRMS (MALDI-FTMS): calcd for C41H48FN2NaO6P (MNa+),
737.3132; found, 737.3127.
Compound 2c. 1H NMR (CDCl3): δ 7.56-7.28 (12H, m), 6.98 (1H,
t, J ) 6.4 Hz), 6.87 (4H, d, J ) 8.6 Hz), 5.23 (1H, dd, J ) 10.0, 5.6
Hz), 4.43 (1H, br s), 4.25-4.10 (1H, m), 3.79 (6H, s), 3.36 (2H, t, J
) 4.8 Hz), 2.33-2.30 (1H, m), 2.05-1.98 (1H, m). 19F NMR (CDCl3):
δ -113.32 (1F, d, J ) 5.3 Hz). 13C NMR (CDCl3): δ 165.6, 160.8,
158.7, 149.5, 145.2, 136.3, 130.4, 130.2, 128.5, 128.1, 127.1, 124.3,
1
Compound 5d. H NMR (CDCl3): δ 7.40-7.15 (10H, m), 7.04-
6.97 (2H, m), 6.76-6.71 (4H, m), 5.04 (1H, dd, J ) 10.5, 5.1 Hz),
4.47-4.39 (1H, m), 4.15-4.06 (1H, m), 3.79-3.40 (4H, m), 3.70 (3H,
s), 3.23-3.18 (2H, m), 2.52 (1H, t, J ) 6.6 Hz), 2.37 (1H, t, J ) 6.6
Hz), 2.30-2.21 (1H, m), 1.93-1.82 (1H, m), 1.13-1.00 (12H, m).
19F NMR (CDCl3): δ -138.2 (1F, m), -140.3 (1F, m). 31P NMR
9
6930 J. AM. CHEM. SOC. VOL. 126, NO. 22, 2004